Trials / Completed
CompletedNCT05737862
Effect of Moringa Oleifera Leaf on Hemoglobin Levels in Anemia
Effect of Moringa Oleifera Leaf Capsul on Hemoglobin Levels in Anemia: A Pilot Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Universitas Padjadjaran · Academic / Other
- Sex
- Female
- Age
- 15 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this study was to compare the results of hemoglobin levels between pregnant women in the treatment group and the control group. Participants will be subjected to anthropometric measurements, recall of food intake for 1 x 24 hours, check hemoglobin before and after being given the intervention and participants in the treatment group are given moringa leaf capsules and iron tablets while participants in the control group are only given iron tablets. Researchers will compare the final results of hemoglobin levels between the treatment group and the control group
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Moringa oleifera capsules | In this arm, pregnant mothers receive capsules containing 500 mg of powdered Moringa oleifera leaves which contain 13.09 mg of iron per100 gram. Dose: 2 × 2 capsules per day for 30 days |
| DIETARY_SUPPLEMENT | iron and folic acid supplements | In this arm, pregnant mothers receive IFA tablets 2 × 1 tablet a day for 30 days. Each IFA tablet contains 400 mcg folic acid and 180 mg Ferrous Fumarate. |
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2022-06-30
- Completion
- 2022-07-30
- First posted
- 2023-02-21
- Last updated
- 2023-03-09
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT05737862. Inclusion in this directory is not an endorsement.